Health / Medical Topics |
Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076
An orally bioavailable synthetic small molecule with potential antiangiogenic and antineoplastic activities. Aurora A kinase/tyrosine kinase inhibitor ENMD-2076 selectively binds to and inhibits non-specified tyrosine kinases and Aurora kinases (AKs). The inhibition of AKs may result in the inhibition of cell division and proliferation and may induce apoptosis in tumor cells that overexpress AKs; antiangiogenic activity is related to the inhibition of angiogenic tyrosine kinases. AKs are serine-threonine kinases that play an essential role in mitotic checkpoint control during mitosis and are important regulators of cell division and proliferation. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally bioavailable, highly selective small molecule inhibitor of the serine/threonine protein kinase Aurora A, with potential antimitotic and antineoplastic activity. Aurora…
Human AURKC wild-type allele is located in the vicinity of 19q13.43 and is approximately 5 kb in length. This allele, which encodes…
This gene is involved in protein phosphorylation and mitosis.
Human AURKB wild-type allele is located in the vicinity of 17p13.1 and is approximately 6 kb in length. This allele, which encodes…
This gene is involved in mitosis and meiosis.
Human AURKA wild-type allele is located within 20q13.2-13.3 and is approximately 23 kb in length. This allele, which encodes serine/threonine-protein kinase 6…